![](https://www.parentprojectmd.org/wp-content/uploads/2018/09/blog_catabasis.png)
Catabasis Pharmaceuticals has shared the latest edition of their community newsletter, which highlights the value of the North Star Ambulatory Assessment in Duchenne.
July 24, 2020 / Clinical Trials
Catabasis Pharmaceuticals has shared the latest edition of their community newsletter, which highlights the value of the North Star Ambulatory Assessment in Duchenne.